Document Detail

Life quality assessment among patients with atopic eczema.
MedLine Citation:
PMID:  16536816     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Quantification of quality of life (QoL) related to disease severity is important in patients with atopic eczema (AE), because the assessment provides additional information to the traditional objective clinical scoring systems. OBJECTIVES: To measure health-related QoL (HRQoL) in patients with AE; to analyse discriminant, divergent and convergent validity by examining the association between various QoL methods; and to examine the association between disease severity assessed by an objective Severity Scoring of Atopic Dermatitis (SCORAD) and QoL. METHODS: HRQoL was assessed at two visits at a 6-monthly interval in 101 patients with AE and 30 controls with one dermatology-specific questionnaire [Dermatology Life Quality Index (DLQI) or Children's DLQI (CDLQI)], one generic instrument (SF-36) and three visual analogue scales (VASs) of severity and pruritus. Objective SCORAD was used to measure disease severity. RESULTS: Patients with AE had significantly lower QoL than healthy controls and the general population. DLQI /CDLQI, pruritus, and patient and investigator overall assessment of eczema severity were significantly (P < 0.0001) and positively correlated with SCORAD, while the generic questionnaire showed only poor correlation. A gender difference was found for the mental component score of SF-36 (P = 0.019). CONCLUSIONS: AE has an impact on HRQoL. Patients' mental health, social functioning and role emotional functioning seem to be more affected than physical functioning. A simple VAS score of patients' assessment of disease severity showed the highest and most significant correlations with most of the HRQoL methods used. There is evidence to support the ability of patients with AE to make an accurate determination of their disease severity and QoL.
E A Holm; H C Wulf; H Stegmann; G B E Jemec
Related Documents :
18782106 - Chronic rhinosinusitis and nasal polyps: the role of generic and specific questionnaire...
19598276 - Relations between depressive and anxious symptoms and quality of life in caregivers of ...
12225336 - Effect of administration mode (patient vs physician) and patient's educational level on...
15702946 - Eq-5d versus sf-6d in an older, chronically ill patient group.
22298536 - A double-blind controlled comparison of fluoxetine and lofepramine in major depressive ...
16434656 - Efficacy and safety of vardenafil in men with erectile dysfunction caused by spinal cor...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Validation Studies    
Journal Detail:
Title:  The British journal of dermatology     Volume:  154     ISSN:  0007-0963     ISO Abbreviation:  Br. J. Dermatol.     Publication Date:  2006 Apr 
Date Detail:
Created Date:  2006-03-15     Completed Date:  2006-08-09     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0004041     Medline TA:  Br J Dermatol     Country:  England    
Other Details:
Languages:  eng     Pagination:  719-25     Citation Subset:  IM    
Division of Dermatology, Roskilde Hospital, University of Copenhagen, Koegevej 7-13, DK 4000 Roskilde, Denmark.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Child, Preschool
Dermatitis, Atopic / physiopathology,  psychology*,  rehabilitation
Health Status Indicators*
Middle Aged
Quality of Life*
Severity of Illness Index

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  In vitro and in vivo comparison of two different light sources for topical photodynamic therapy.
Next Document:  Etanercept: effective in the management of hidradenitis suppurativa.